- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04569253
Multi-Center Pivotal Study of Radiofrequency Device
June 9, 2022 updated by: Cynosure, Inc.
Clinical Study to Assess the Safety and Efficacy of the Tempsure® Firm for Non-invasive Lipolysis of the Flanks.
This is a prospective, controlled, multi-center study.
Patients will be enrolled and treated with a radiofrequency device in this study if they have unwanted fat in the flank (love handle) area.
Study Overview
Detailed Description
Subjects are to be enrolled in this clinical study if they are 18 - 55 years old.
A maximum of 55 subjects will be enrolled at up to 6 study centers.
Subjects will receive up to 5 treatments with the TempSure® Firm on one flank.
The other flank will be left untreated to serve a control.
Subject will be required to return for follow-up visits at 6 weeks and at 12 weeks after the subject's final treatment.
All subjects will receive a phone call 1 week (1-10 days) post each treatment.
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Hunt Valley, Maryland, United States, 21030
- Maryland Dermatology Laser, Skin, & Vein Institute, LLC.
-
-
New York
-
New York, New York, United States, 10022
- Juva Skin & Laser Center
-
Rye, New York, United States, 10580
- Jeremy A Brauer MD PC
-
-
North Carolina
-
Huntersville, North Carolina, United States, 28078
- Saluja Cosmetic and Laser Center
-
-
Pennsylvania
-
Plymouth Meeting, Pennsylvania, United States, 19462
- Dermatology Associates of Plymouth Meeting, P.C.
-
-
Virginia
-
Virginia Beach, Virginia, United States, 23462
- McDaniel Institute of Anti-Aging Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- A healthy male or female between the age of 18 - 55 years old.
- Willing to undergo treatments for fat reduction of the flank area (love handle)
- Understands and accepts obligation not to receive any other procedures on the treatment area through the length of the study.
- Understands and accepts the obligation and is logistically able to be present for all visits.
- Is willing to comply with all requirements of the study and sign the informed consent document
Exclusion Criteria:
- Is pregnant or of childbearing potential and not using medically effective birth control, or has been pregnant in the last 3 months, currently breast feeding or planning a pregnancy during the study.
- The subject has a cut, wound, or infected skin on the area to be treated.
- The subject is on local, oral, or systemic anesthetic agents.
- The subject has any condition or is in a situation which in the investigators opinion may put the subject at significant risk, may confound study results or may interfere significantly with the subject's participation.
- The subject is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within in the area to be treated 6 months (or at the discretion of the Investigator) prior to entering this study.
Cautionary Criteria:
- The subject has any embedded electronic device that gives or receives a signal, the device should be turned off or removed prior to treatment.
- The subject has an embedded pacemaker or implantable cardioverter defibrillator (ICD), the client's cardiologist must be consulted prior to treatment.
NOTE: This device has not been tested on patients implanted with electronic devices that receive or emit signals, such as: Pacemakers, Implantable Cardiac Defibrillators (ICD), or Cardiac Resynchronization Therapy (CRT) devices.
- If the neutral pad would need to be placed on a subject that has a metal plate, rod, or any metal implant that could conduct heat from the Smart Handpiece or surgical handpiece.
- The subject is allergic to adhesives, such as glues on medical tape, they should be alerted that a rash may occur on the neutral pad site and an over the counter solution may be used to treat the area.
- The subject is allergic to gold, such as the metallic covering of the TempSure handpieces.
- The subject is allergic to corn, such as the corn derivative ingredient in Parker Aquasonic Gel.
- If the subject has an unhealthy expectation of the results - this is not plastic surgery and all subject should be fully informed of the treatment's expected results.
- The subject has nerve insensitivity to heat in the treatment area.
- The subject has severe laxity or sagging that causes redundant folds of tissue or hanging skin in the area to be treated - this treatment will be ineffective.
- The subject has used Accutane (Isotretinoin) six to twelve months prior to treatment, as this can thin the skin and make it brittle.
- Studies of the use of the RF generator on subjects that have any of the following conditions is unknown:
Autoimmune Disease Diabetic Herpes Simplex
- Use caution when treating areas that have scars, tattoos, permanent makeup, and permanent brows.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: All study participants
Subjects will receive treatments with the RF device on one flank.
The other flank will be left untreated to serve a control.
|
Non-invasive radiofrequency treatments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
% of Photos Identified Correctly When Comparing 12 Week Follow Up to Baseline
Time Frame: 12 Week Follow Up
|
Correct identification of pre-treatment images vs. the 12-week follow up images by blinded evaluators.
|
12 Week Follow Up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Jennifer Civiok, Cynosure, Inc.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 28, 2020
Primary Completion (Actual)
March 26, 2021
Study Completion (Actual)
March 26, 2021
Study Registration Dates
First Submitted
August 27, 2020
First Submitted That Met QC Criteria
September 24, 2020
First Posted (Actual)
September 29, 2020
Study Record Updates
Last Update Posted (Actual)
June 14, 2022
Last Update Submitted That Met QC Criteria
June 9, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- CYN20-FIRM-LIPO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Fat
-
Cutera Inc.Completed
-
Chonbuk National University HospitalUnknownBody FatKorea, Republic of
-
Aguiflai Iberica, S.L.Completed
-
Cynosure, Inc.Terminated
-
Cutera Inc.CompletedBody FatUnited States
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
-
Zeltiq AestheticsCompleted
Clinical Trials on TempSure
-
Cynosure, Inc.CompletedSkin LaxityUnited States
-
Cynosure, Inc.CompletedNon-invasive LipolysisUnited States
-
Cynosure, Inc.CompletedBenign Pigmented Lesions | Wrinkle | Benign Vascular LesionsUnited States
-
Cynosure, Inc.Terminated
-
Cynosure, Inc.CompletedCoagulation | Tissue HeatingUnited States